Market Overview

Merida Capital Adds Former Omnicom Group and Medco Health Solutions Executives to Operating Team

Share:

Merida
Capital Partners
(Merida), a private equity firm focused on
high-conviction investments in the cannabis ecosystem, announced it
added former Omnicom
Group Inc.
(NYSE: OMC)
executive Tom Harrison and former Medco
Health Solutions, Inc.
executive Pamela Galassini as senior
operating partners.

Both executives bring extensive corporate experience to Merida and will
focus on supporting the firm and its portfolio
companies
in the healthcare, media and data sectors. Initially,
Harrison will join the board of directors of MediaJel,
a global creative and multimedia agency while Galassini will join Manna
Molecular
, a cannabis biotech and product innovation firm, in an
operations executive role. In the coming months, both senior operating
partners will assume additional corporate roles at the firm as well as
with Merida's portfolio companies.

"As our portfolio grows in size and complexity, executives like Tom and
Pam with institutional backgrounds in healthcare, media and
pharmaceuticals will allow our firm to further drive our cannabis
ecosystem strategy, while giving our portfolio companies more hands-on
support needed to manage their hyper-growth responsibly," said Mitchell
Baruchowitz, Merida Capital Partners, managing partner.

Tom Harrison

Harrison, previously the president, chairman and CEO of Diversified
Agency Services
(DAS), a global group of marketing services
companies and division of Omnicom Group Inc., now serves as chairman
emeritus. Under Harrison's nearly 20-year tenure, DAS grew to become the
largest worldwide holding company of entrepreneur-led marketing services
companies competing in the public relations, CRM,
promotional/experiential/field marketing, branding, research, events and
talent procurement, along with clinically-focused companies in the
healthcare and wellness sectors.

Harrison is a former board
member
of Zynerba
Pharmaceuticals
(NASDAQ: ZYNE)
and currently serves on the boards of Montefiore
Health System
and Madison
Logic
. Additionally, Harrison was elected by his peers as a
New York Academy of Medicine
fellow; served as a member of
The New York Academy of Sciences
; is a recipient of the
Ellis Island Medal of Honor
; and holds an honorary doctorate from
West Virginia University, where he earned a graduate degree in cell
biology and physiology.

"The undeniable clinical importance and versatility of cannabis and CBD
is changing the healthcare and wellness landscape," said Harrison. "I am
excited to work alongside such a talented and diverse group of
entrepreneurial leaders in this dynamic space to add strategic value and
help accelerate growth for the firm and its portfolio companies which
are poised to benefit greatly from these positive market changes."

Pamela Galassini

Galassini brings more than 20 years of pharmacy benefit management,
payor insights and pharmaceutical manufacturer strategies and solutions
experience to Merida. Throughout the nearly two decades spent at Medco
Health Solutions, Inc., which was acquired for $29B by Express
Scripts
in 2011, Pam served in a number of roles within the
organization, including as the company's Pharmaceutical Strategies &
Solutions Senior Vice President, Government & Labor Senior Vice
President and the Central Region Vice President of Sales.

Additionally, Galassini served as the CEO of Leafline
Labs
, one of only two medical cannabis vertical operators licensed
in the state of Minnesota. She holds a B.S. in Speech Communication and
Rhetoric from the University of Illinois.

"After years of failing to comprehensively address our nation's ongoing
opioids crisis and flawed healthcare policies, consumers are now
demanding smarter health and wellness solutions," said Galassini. "As a
new era in responsible, plant-based health and wellness solutions dawns,
I am eager to bring my years of healthcare experience to Merida, Manna
Molecular and Merida's portfolio of cannabis and hemp companies."

About Merida Capital Partners

Merida Capital Partners is a private equity firm targeting fundamental
growth drivers which accelerate the rapid development of the cannabis
and hemp industries. Merida's motto, Responsible Investing in the
Cannabis Ecosystem,
highlights its focus on cultivation
technologies, products and services associated with the evolution of
cannabis and hemp as agricultural products, plant-based medicines,
constituents in pharmaceutical formulations and recreational consumer
products. For more information, visit www.meridacap.com
or follow us on Twitter @meridacap.

View Comments and Join the Discussion!
 
Lightning Fast
Market News Service
$199 Free 14 Day Trial